Mather Group’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$57.8K Sell
671
-84
-11% -$7.37K ﹤0.01% 1072
2026
Q1
$68.3K Buy
+755
New +$69.3K ﹤0.01% 992
2025
Q4
Sell
-365
Closed -$35.9K 1674
2025
Q3
$35.9K Buy
+365
New +$36.2K ﹤0.01% 985
2025
Q2
Sell
-513
Closed -$58.1K 1756
2025
Q1
$58.1K Sell
513
-148
-22% -$15.8K ﹤0.01% 870
2024
Q4
$69.8K Buy
661
+332
+101% +$35.6K ﹤0.01% 808
2024
Q3
$35.5K Sell
329
-316
-49% -$34.5K ﹤0.01% 946
2024
Q2
$85.1K Buy
645
+56
+10% +$6.6K ﹤0.01% 854
2024
Q1
$71.7K Buy
+589
New +$73.6K ﹤0.01% 794

Other funds holding ZBH

Mather Group's ZBH Position: Q2 2026 in Review

Mather Group reduced its Zimmer Biomet (ZBH) stake by 11% in Q2 2026, selling an estimated $7.37K and leaving 671 shares worth $57.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1072.

Mather Group first reported a position in ZBH in Q1 2024 and has held it in 8 quarters since. The position peaked at $85.1K in Q2 2024. 909 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • Mather Group held 671 shares of Zimmer Biomet worth $57.8K as of Q2 2026.
  • Mather Group sold 84 Zimmer Biomet shares in Q2 2026, an estimated $7.37K.
  • Zimmer Biomet made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1072 holding.
  • Mather Group first reported a position in Zimmer Biomet in Q1 2024 and has held it in 8 quarters since.
  • Mather Group's Zimmer Biomet position peaked at $85.1K in Q2 2024.
  • 909 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.